Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
32
CIM Quote, Financials, Valuation and Earnings
Last price:
$13.37
Seasonality move
:
-5.65%
Day range:
$13.29 - $13.63
52-week range:
$9.85 - $14.88
Dividend yield:
7.76%
P/E ratio:
7.62x
P/S ratio:
1.29x
P/B ratio:
0.68x
Volume:
687.1K
Avg. volume:
942.2K
1-year change:
-2.98%
Market cap:
$1.1B
Revenue:
$850.6M
EPS (TTM):
$1.75
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CIM
Chimera Investment Corp.
|
$80.8M | $0.50 | -59.87% | -72.05% | $14.83 |
|
AXR
AMREP Corp.
|
$14M | -- | 86.17% | -- | $23.00 |
|
GCCO
Garden City Co.
|
-- | -- | -- | -- | -- |
|
UCASU
UC Asset LP
|
-- | -- | -- | -- | -- |
|
VGLS
VG Life Sciences
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CIM
Chimera Investment Corp.
|
$13.35 | $14.83 | $1.1B | 7.62x | $0.37 | 7.76% | 1.29x |
|
AXR
AMREP Corp.
|
$27.06 | $23.00 | $143.6M | 13.84x | $0.00 | 0% | 3.17x |
|
GCCO
Garden City Co.
|
$1,800.00 | -- | $62.8M | -- | $40.00 | 1.11% | -- |
|
UCASU
UC Asset LP
|
$0.43 | -- | $2.3M | 329.22x | $0.00 | 0% | 3.47x |
|
VGLS
VG Life Sciences
|
$0.0001 | -- | $2.1M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CIM
Chimera Investment Corp.
|
83.55% | 1.113 | 667.3% | 0.04x |
|
AXR
AMREP Corp.
|
0.02% | 1.521 | 0.02% | 11.04x |
|
GCCO
Garden City Co.
|
-- | 0.394 | -- | -- |
|
UCASU
UC Asset LP
|
-- | 10.279 | -- | -- |
|
VGLS
VG Life Sciences
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CIM
Chimera Investment Corp.
|
$208.8M | $191.3M | 1.64% | 8.91% | 90.36% | -$152.8M |
|
AXR
AMREP Corp.
|
$3.1M | $1.1M | 8.05% | 8.06% | 11.91% | -$4.3M |
|
GCCO
Garden City Co.
|
-- | -- | -- | -- | -- | -- |
|
UCASU
UC Asset LP
|
-- | -- | -- | -- | -- | -- |
|
VGLS
VG Life Sciences
|
-- | -- | -- | -- | -- | -- |
Chimera Investment Corp. vs. Competitors
-
Which has Higher Returns CIM or AXR?
AMREP Corp. has a net margin of 12.93% compared to Chimera Investment Corp.'s net margin of 12.77%. Chimera Investment Corp.'s return on equity of 8.91% beat AMREP Corp.'s return on equity of 8.06%.
Company Gross Margin Earnings Per Share Invested Capital CIMChimera Investment Corp.95.28% $0.08 $15.6B AXRAMREP Corp.32.72% $0.22 $136.1M -
What do Analysts Say About CIM or AXR?
Chimera Investment Corp. has a consensus price target of $14.83, signalling upside risk potential of 11.11%. On the other hand AMREP Corp. has an analysts' consensus of $23.00 which suggests that it could fall by -15%. Given that Chimera Investment Corp. has higher upside potential than AMREP Corp., analysts believe Chimera Investment Corp. is more attractive than AMREP Corp..
Company Buy Ratings Hold Ratings Sell Ratings CIMChimera Investment Corp.1 4 0 AXRAMREP Corp.1 0 0 -
Is CIM or AXR More Risky?
Chimera Investment Corp. has a beta of 1.840, which suggesting that the stock is 83.961% more volatile than S&P 500. In comparison AMREP Corp. has a beta of 1.443, suggesting its more volatile than the S&P 500 by 44.267%.
-
Which is a Better Dividend Stock CIM or AXR?
Chimera Investment Corp. has a quarterly dividend of $0.37 per share corresponding to a yield of 7.76%. AMREP Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chimera Investment Corp. pays 86% of its earnings as a dividend. AMREP Corp. pays out -- of its earnings as a dividend. Chimera Investment Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CIM or AXR?
Chimera Investment Corp. quarterly revenues are $219.1M, which are larger than AMREP Corp. quarterly revenues of $9.4M. Chimera Investment Corp.'s net income of $28.3M is higher than AMREP Corp.'s net income of $1.2M. Notably, Chimera Investment Corp.'s price-to-earnings ratio is 7.62x while AMREP Corp.'s PE ratio is 13.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chimera Investment Corp. is 1.29x versus 3.17x for AMREP Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CIMChimera Investment Corp.1.29x 7.62x $219.1M $28.3M AXRAMREP Corp.3.17x 13.84x $9.4M $1.2M
-
Which has Higher Returns CIM or GCCO?
Garden City Co. has a net margin of 12.93% compared to Chimera Investment Corp.'s net margin of --. Chimera Investment Corp.'s return on equity of 8.91% beat Garden City Co.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CIMChimera Investment Corp.95.28% $0.08 $15.6B GCCOGarden City Co.-- -- -- -
What do Analysts Say About CIM or GCCO?
Chimera Investment Corp. has a consensus price target of $14.83, signalling upside risk potential of 11.11%. On the other hand Garden City Co. has an analysts' consensus of -- which suggests that it could fall by --. Given that Chimera Investment Corp. has higher upside potential than Garden City Co., analysts believe Chimera Investment Corp. is more attractive than Garden City Co..
Company Buy Ratings Hold Ratings Sell Ratings CIMChimera Investment Corp.1 4 0 GCCOGarden City Co.0 0 0 -
Is CIM or GCCO More Risky?
Chimera Investment Corp. has a beta of 1.840, which suggesting that the stock is 83.961% more volatile than S&P 500. In comparison Garden City Co. has a beta of 0.414, suggesting its less volatile than the S&P 500 by 58.592%.
-
Which is a Better Dividend Stock CIM or GCCO?
Chimera Investment Corp. has a quarterly dividend of $0.37 per share corresponding to a yield of 7.76%. Garden City Co. offers a yield of 1.11% to investors and pays a quarterly dividend of $40.00 per share. Chimera Investment Corp. pays 86% of its earnings as a dividend. Garden City Co. pays out -- of its earnings as a dividend. Chimera Investment Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CIM or GCCO?
Chimera Investment Corp. quarterly revenues are $219.1M, which are larger than Garden City Co. quarterly revenues of --. Chimera Investment Corp.'s net income of $28.3M is higher than Garden City Co.'s net income of --. Notably, Chimera Investment Corp.'s price-to-earnings ratio is 7.62x while Garden City Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chimera Investment Corp. is 1.29x versus -- for Garden City Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CIMChimera Investment Corp.1.29x 7.62x $219.1M $28.3M GCCOGarden City Co.-- -- -- --
-
Which has Higher Returns CIM or UCASU?
UC Asset LP has a net margin of 12.93% compared to Chimera Investment Corp.'s net margin of --. Chimera Investment Corp.'s return on equity of 8.91% beat UC Asset LP's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CIMChimera Investment Corp.95.28% $0.08 $15.6B UCASUUC Asset LP-- -- -- -
What do Analysts Say About CIM or UCASU?
Chimera Investment Corp. has a consensus price target of $14.83, signalling upside risk potential of 11.11%. On the other hand UC Asset LP has an analysts' consensus of -- which suggests that it could grow by 834.6%. Given that UC Asset LP has higher upside potential than Chimera Investment Corp., analysts believe UC Asset LP is more attractive than Chimera Investment Corp..
Company Buy Ratings Hold Ratings Sell Ratings CIMChimera Investment Corp.1 4 0 UCASUUC Asset LP0 0 0 -
Is CIM or UCASU More Risky?
Chimera Investment Corp. has a beta of 1.840, which suggesting that the stock is 83.961% more volatile than S&P 500. In comparison UC Asset LP has a beta of 3.020, suggesting its more volatile than the S&P 500 by 201.974%.
-
Which is a Better Dividend Stock CIM or UCASU?
Chimera Investment Corp. has a quarterly dividend of $0.37 per share corresponding to a yield of 7.76%. UC Asset LP offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chimera Investment Corp. pays 86% of its earnings as a dividend. UC Asset LP pays out -- of its earnings as a dividend. Chimera Investment Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CIM or UCASU?
Chimera Investment Corp. quarterly revenues are $219.1M, which are larger than UC Asset LP quarterly revenues of --. Chimera Investment Corp.'s net income of $28.3M is higher than UC Asset LP's net income of --. Notably, Chimera Investment Corp.'s price-to-earnings ratio is 7.62x while UC Asset LP's PE ratio is 329.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chimera Investment Corp. is 1.29x versus 3.47x for UC Asset LP. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CIMChimera Investment Corp.1.29x 7.62x $219.1M $28.3M UCASUUC Asset LP3.47x 329.22x -- --
-
Which has Higher Returns CIM or VGLS?
VG Life Sciences has a net margin of 12.93% compared to Chimera Investment Corp.'s net margin of --. Chimera Investment Corp.'s return on equity of 8.91% beat VG Life Sciences's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital CIMChimera Investment Corp.95.28% $0.08 $15.6B VGLSVG Life Sciences-- -- -- -
What do Analysts Say About CIM or VGLS?
Chimera Investment Corp. has a consensus price target of $14.83, signalling upside risk potential of 11.11%. On the other hand VG Life Sciences has an analysts' consensus of -- which suggests that it could fall by --. Given that Chimera Investment Corp. has higher upside potential than VG Life Sciences, analysts believe Chimera Investment Corp. is more attractive than VG Life Sciences.
Company Buy Ratings Hold Ratings Sell Ratings CIMChimera Investment Corp.1 4 0 VGLSVG Life Sciences0 0 0 -
Is CIM or VGLS More Risky?
Chimera Investment Corp. has a beta of 1.840, which suggesting that the stock is 83.961% more volatile than S&P 500. In comparison VG Life Sciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CIM or VGLS?
Chimera Investment Corp. has a quarterly dividend of $0.37 per share corresponding to a yield of 7.76%. VG Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Chimera Investment Corp. pays 86% of its earnings as a dividend. VG Life Sciences pays out -- of its earnings as a dividend. Chimera Investment Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CIM or VGLS?
Chimera Investment Corp. quarterly revenues are $219.1M, which are larger than VG Life Sciences quarterly revenues of --. Chimera Investment Corp.'s net income of $28.3M is higher than VG Life Sciences's net income of --. Notably, Chimera Investment Corp.'s price-to-earnings ratio is 7.62x while VG Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Chimera Investment Corp. is 1.29x versus -- for VG Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CIMChimera Investment Corp.1.29x 7.62x $219.1M $28.3M VGLSVG Life Sciences-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
ACLX alert for Feb 24
Arcellx, Inc. [ACLX] is up 77.43% over the past day.
Buy
65
RNG alert for Feb 24
RingCentral, Inc. [RNG] is down 12.48% over the past day.
Buy
71
SNSE alert for Feb 24
Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.
